Biocryst Pharmaceuticals buy Royal Bank of Canada
Start price
25.02.25
/
50%
€7.79
Target price
25.02.26
€10.47
Performance (%)
-19.06%
End price
26.02.26
€6.30
Summary
This prediction ended on 26.02.26 with a price of €6.30. The price of Biocryst Pharmaceuticals has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -19.06%. Royal_Bank_of_Canada has a follow-up prediction for Biocryst Pharmaceuticals where he still thinks Biocryst Pharmaceuticals is a Buy. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Biocryst Pharmaceuticals | 19.437% | 19.437% | 17.172% |
| iShares Core DAX® | -4.932% | -11.977% | -3.485% |
| iShares Nasdaq 100 | -2.634% | -2.218% | 13.783% |
| iShares Nikkei 225® | -4.733% | -10.900% | 19.712% |
| iShares S&P 500 | -2.544% | -3.540% | 8.878% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Biocryst Pharmaceuticals diskutieren
BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $11.00 price target on the stock, up previously from $10.00.
Ratings data for BCRX provided by MarketBeat
In the thread Trading Biocryst Pharmaceuticals
Die von Royal_Bank_of_Canada gewählte maximale Laufzeit wurde überschritten
Current prediction by Royal_Bank_of_Canada for Biocryst Pharmaceuticals
Biocryst Pharmaceuticals
Start price
Target price
Perf. (%)
€5.91
11.04.25
11.04.25
€9.75
11.04.26
11.04.26
46.40%
20.03.26
20.03.26
Stopped prediction by Royal_Bank_of_Canada for Biocryst Pharmaceuticals
Biocryst Pharmaceuticals
Start price
Target price
Perf. (%)
€5.59
30.01.26
30.01.26
€10.92
30.01.27
30.01.27
54.89%
20.03.26
20.03.26
Biocryst Pharmaceuticals
Start price
Target price
Perf. (%)
€7.60
30.06.25
30.06.25
€11.09
30.06.26
30.06.26
13.81%
20.03.26
20.03.26
Biocryst Pharmaceuticals
Start price
Target price
Perf. (%)
€8.90
06.05.25
06.05.25
€11.51
06.05.26
06.05.26
-2.76%
20.03.26
20.03.26
Biocryst Pharmaceuticals
Start price
Target price
Perf. (%)
€6.61
05.11.24
05.11.24
€9.16
05.11.25
05.11.25
-6.99%
06.11.25
06.11.25
Biocryst Pharmaceuticals
Start price
Target price
Perf. (%)
€6.95
25.09.23
25.09.23
€9.44
25.09.24
25.09.24
-2.42%
26.09.24
26.09.24